September 2013 Oncology
Oral antineoplastics have advantages, but patient adherence is a concern.
Gilotrif (afatinib) is FDA approved for treating certain non-small cell lung cancers.
Why are computerized drug-drug interaction alerts usually ignored?
Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.
The nutritional supplements glucosamine and chondroitin have demonstrated some potential for reducing pain associated with osteoarthritis
Federal rules are very specific.
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
2
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
First-in-Human In Vivo CAR-T Therapy Shows Encouraging Activity in Relapsed/Refractory Multiple Myeloma
5